Cash flows from operating activities: | |
Net loss | 369.58M |
Adjustments to reconcile net loss to cash used in operating activities: | |
Depreciation and amortization | 134.46M |
Asset impairment | 0 |
Noncash loss on early extinguishment of debt recognized as a reorganization item | |
Accretion of bond discount | |
Gain on property disposals | |
Share-based compensation | 5.4M |
Deferred income tax benefit | -1.29M |
Changes in operating assets and liabilities: | |
Restricted cash and cash equivalents | |
Trade accounts and other receivables | -2.64M |
Inventories | 4.55M |
Prepaid expenses and other current assets | -83K |
Accounts payable, accrued expenses and other current liabilities | -7.81M |
Income taxes | 45.22M |
Deposits | |
Other operating assets and liabilities | -864K |
Cash used in operating activities | 531.11M |
Cash flows from investing activities: | |
Acquisitions of property, plant and equipment | |
Purchases of investment securities | |
Proceeds from sale or maturity of investment securities | |
Proceeds from property disposals | |
Cash used in investing activities | -163.12M |
Cash flows from financing activities: | |
Proceeds from note payable to JBS USA | |
Proceeds from revolving line of credit and long-term borrowings | 515.29M |
Payments on revolving line of credit, long-term borrowings and capital lease obligations | -498.12M |
Proceeds from sale of common stock | |
Purchase of remaining interest in subsidiary | |
Payment of capitalized loan costs | |
Other financing activities | |
Cash provided by (used in) financing activities | -721.63M |
Effect of exchange rate changes on cash and cash equivalents | |
Decrease in cash and cash equivalents | -353.64M |
Cash and cash equivalents, beginning of period | 439.64M |
Cash and cash equivalents, end of period | 85.99M |